用于治疗肺癌的靶向治疗的肾毒性。
关键词: ALK TKIs EGFR TKIs lung cancer nephrotoxicity targeted therapy
Mesh : Humans Lung Neoplasms / drug therapy Molecular Targeted Therapy / adverse effects Protein Kinase Inhibitors / adverse effects therapeutic use Antineoplastic Agents / adverse effects therapeutic use Anaplastic Lymphoma Kinase / antagonists & inhibitors ErbB Receptors / antagonists & inhibitors Animals Kidney Diseases / chemically induced Kidney / drug effects pathology metabolism Carcinoma, Non-Small-Cell Lung / drug therapy
来 源:
DOI:10.3389/fimmu.2024.1369118
PDF(Pubmed)